SINGAPORE (Apr 28): Acromec, a specialist engineering service provider that serves the healthcare, biomedical, pharmaceutical, research and academia sectors, has secured a sub-contract worth $5.6 million for a client in the biotechnology research and development sector.

The contract will be to fit out for the client’s state-of-the-art production suites and distribution centres for gene expression solutions, including the production of test kits for distribution across Asia.

Acromec expects this contract to contribute positively to its earnings per share and net tangible assets per share for the current financial year ending on September 30. This contract is expected to be completed in the same month.

As at 1.10pm, Acromec shares remain flat at 5.1 cents.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $4.99/month*

The latest reporting and analysis from business and investments to news and views on social issues.

Bonus:

  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply

SUBSCRIBE NOW